CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹6,821 Cr | ₹5,702 Cr | ₹4,038 Cr | ₹3,493 Cr | ₹3,290 Cr |
What is the latest Profit Before Tax of CIPLA ?
| Year | Profit Before Tax |
|---|---|
| Mar2026 | ₹6,821 Cr |
| Mar2025 | ₹5,702 Cr |
| Mar2024 | ₹4,038 Cr |
| Mar2023 | ₹3,493 Cr |
| Mar2022 | ₹3,290 Cr |
How is Profit Before Tax of CIPLA Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹6,821 Cr | 19.62 | |
| Mar2025 | ₹5,702 Cr | 41.19 | |
| Mar2024 | ₹4,038 Cr | 15.60 | |
| Mar2023 | ₹3,493 Cr | 6.18 | |
| Mar2022 | ₹3,290 Cr | - | |
Compare Profit Before Tax of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹118,922.9 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| MANKIND PHARMA | ₹100,730.0 Cr | -1.4% | -3.7% | -5.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 0.2% |
2.1% |
-5.1% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses